Elucidating the specific pharmacological mechanism of action (MOA) of naturally occurring compounds is often demanding. Although Tarselli et al. (60) designed the main de novo synthetic pathway to conolidine and showcased that this naturally taking place compound properly suppresses responses to both of those chemically induced and inflammation-derived pain, https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers